Oramed Pharmaceuticals (ORMP) Return on Equity (ROE) (2008 - 2026)
Oramed Pharmaceuticals (ORMP) Return on Equity (ROE) from Aug 31, 2008 to Mar 31, 2026. The TTM Oramed Pharmaceuticals (ORMP) Return on Equity (ROE) is 16.08%. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual ROE
Quarterly ROE
Annual Return on Equity (ROE) change of Oramed Pharmaceuticals (ORMP)
| Year | Return on Equity (ROE) | Change |
|---|---|---|
| 2025 | 32.07% | -346.07% |
| 2024 | -13.03% | -519.42% |
| 2023 | 3.11% | -112.90% |
| 2022 | -24.08% | +227.23% |
| 2021 | -7.36% | -62.94% |
| 2021 | -19.86% | -43.27% |
| 2020 | -35.01% | -52.70% |
| 2019 | -74.01% | +80.86% |
| 2018 | -40.92% | -24.88% |
| 2017 | -54.47% | +30.16% |
| 2016 | -41.85% | +43.72% |
| 2015 | -29.12% | +6.20% |
| 2014 | -27.42% | -152.70% |
| 2013 | 52.03% | -158.88% |
| 2012 | -88.36% | +110.70% |
| 2011 | -41.94% | -88.32% |
| 2010 | -359.04% | +257.74% |
| 2009 | -100.36% | +66.31% |
| 2008 | -60.35% | N/A |